Aches? Pains? An Extra Dose Of Vitamin D May Provide Relief Pain is the most common complaint leading patients to seek medical care and much of it is chronic, lasting 3 months or longer. According to an extensive review of clinical research in a new report from Pain Treatment Topics, inadequate vitamin D intake has been linked to a long list of chronic painful maladies, including bone and joint pain of various types, muscle pain, fibromyalgia syndrome, rheumatic disorders, osteoarthritis, and other complaints.
Source: www.medicalnewstoday.comFDA Approves Cymbalta� For The Management Of Fibromyalgia The U.S. Food and Drug Administration (FDA) has approved Cymbalta� (duloxetine HCl) for the management of fibromyalgia, a chronic widespread pain disorder, Eli Lilly and Company (NYSE: LLY) announced. Cymbalta is the first serotonin- norepinephrine reuptake inhibitor with proven efficacy for reducing pain in patients with fibromyalgia. The fibromyalgia indication represents the second FDA-approved use for Cymbalta for a pain disorder, demonstrating the medication's analgesic effect.
Source: www.medicalnewstoday.comHealthLinx And InSymbiosis To Co-Develop Therapeutic For Lung Disease HealthLinx Limited (ASX:HTX) and Canadian-based InSymbiosis Discovery Inc (InSymbiosis) have signed a Letter of Intent to co-develop HTX's peptide therapeutic CR014 and related compounds for applications in Acute Respiratory Distress Syndrome (ARDS) and Acute Lung Injury. The companies will proceed under a joint venture agreement subject to the completion of due diligence.
Source: www.medicalnewstoday.comLabels: No Prescription, Online Pharmacy
# posted by Network @ 4:00 PM
